These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8375803)

  • 21. [Clinical and molecular genetics of hypertrophic cardiomyopathy].
    Sepp R; Csanády M
    Orv Hetil; 1998 Aug; 139(33):1965-71. PubMed ID: 9734214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetics of hypertrophic cardiomyopathy.
    Marian AJ; Roberts R
    Annu Rev Med; 1995; 46():213-22. PubMed ID: 7598458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current perspective new insights into the molecular basis of familial dilated cardiomyopathy.
    Sinagra G; Di Lenarda A; Brodsky GL; Taylor MR; Muntoni F; Pinamonti B; Carniel E; Driussi M; Bristow MR; Mestroni L;
    Ital Heart J; 2001 Apr; 2(4):280-6. PubMed ID: 11374497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11.
    Carrier L; Hengstenberg C; Beckmann JS; Guicheney P; Dufour C; Bercovici J; Dausse E; Berebbi-Bertrand I; Wisnewsky C; Pulvenis D
    Nat Genet; 1993 Jul; 4(3):311-3. PubMed ID: 8358441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
    Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
    Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [High-risk hypertrophic cardiomyopathy associated with a novel mutation in cardiac Myosin-binding protein C].
    García-Pavía P; Segovia J; Molano J; Mora R; Kontny F; Erik Berge K; Leren TP; Alonso-Pulpón L
    Rev Esp Cardiol; 2007 Mar; 60(3):311-4. PubMed ID: 17394878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene.
    Bonne G; Mercuri E; Muchir A; Urtizberea A; Bécane HM; Recan D; Merlini L; Wehnert M; Boor R; Reuner U; Vorgerd M; Wicklein EM; Eymard B; Duboc D; Penisson-Besnier I; Cuisset JM; Ferrer X; Desguerre I; Lacombe D; Bushby K; Pollitt C; Toniolo D; Fardeau M; Schwartz K; Muntoni F
    Ann Neurol; 2000 Aug; 48(2):170-80. PubMed ID: 10939567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertrophic cardiomyopathy.
    Capek P; Brdicka R
    Cas Lek Cesk; 2006; 145(2):93-6; discussion 96-7. PubMed ID: 16521396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.
    Taylor MR; Carniel E; Mestroni L
    Expert Rev Mol Diagn; 2004 Jan; 4(1):99-113. PubMed ID: 14711353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.
    Cuda G; Fananapazir L; Zhu WS; Sellers JR; Epstein ND
    J Clin Invest; 1993 Jun; 91(6):2861-5. PubMed ID: 8514894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.
    Jefferies JL; Eidem BW; Belmont JW; Craigen WJ; Ware SM; Fernbach SD; Neish SR; Smith EO; Towbin JA
    Circulation; 2005 Nov; 112(18):2799-804. PubMed ID: 16246949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetics of hypertrophic cardiomyopathies: what are the clinical perspectives?].
    Komajda M
    Arch Mal Coeur Vaiss; 1996 Jul; 89 Spec No 2():11-4. PubMed ID: 8881500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exclusion of genes coding for proteins of the cytoskeleton and the extracellular matrix in familial hypertrophic cardiomyopathy using a candidate gene approach.
    Dufour C; Carrier L; Hengstenberg C; Bercovici J; Dausse E; Weissenbach J; Dubourg O; Komajda M; Schwartz K; Beckmann JS
    C R Acad Sci III; 1993; 316(5):474-81. PubMed ID: 8221230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant mutations in hypertrophic cardiomyopathy: fact or fancy?
    Brito D; Madeira H
    Rev Port Cardiol; 2005 Sep; 24(9):1137-46. PubMed ID: 16335287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial hypertrophic cardiomyopathy associated with a novel missense mutation affecting the ATP-binding region of the cardiac beta-myosin heavy chain.
    Bundgaard H; Havndrup O; Andersen PS; Larsen LA; Brandt NJ; Vuust J; Kjeldsen K; Christiansen M
    J Mol Cell Cardiol; 1999 Apr; 31(4):745-50. PubMed ID: 10329202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cardiomyopathies].
    Schwartz K
    Pathol Biol (Paris); 1997 Mar; 45(3):213-7. PubMed ID: 9296066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C
    Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy.
    Carrier L; Bonne G; Bährend E; Yu B; Richard P; Niel F; Hainque B; Cruaud C; Gary F; Labeit S; Bouhour JB; Dubourg O; Desnos M; Hagège AA; Trent RJ; Komajda M; Fiszman M; Schwartz K
    Circ Res; 1997 Mar; 80(3):427-34. PubMed ID: 9048664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sarcomere protein gene mutations and inherited heart disease: a beta-cardiac myosin heavy chain mutation causing endocardial fibroelastosis and heart failure.
    Kamisago M; Schmitt JP; McNamara D; Seidman C; Seidman JG
    Novartis Found Symp; 2006; 274():176-89; discussion 189-95, 272-6. PubMed ID: 17019812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.